References
1. Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev 2005; 18:44-69.
2. Levin T, Suh B, Beltramo D, Samuel R. Aspergillus mediastinitis following orthotopic heart transplantation: case report and review of the literature. Transpl Infect Dis 2004; 6:129-31.
3. Chou NK, Wang JL, Chi NH, et al. Surgical treatment of mediastinitis after cardiac transplantation. Transplant Proc 2008; 40:2629-30.
4. Forestier E, Remy V, Lesens O, et al. A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B, caspofungin and voriconazole. Eur J Clin Microbiol 2005; 24:347-9.
5. Zbinden A, Imhof A, Wilhelm MJ, et al. Fatal outcome after heart transplantation caused by Aspergillus lentulus. Transpl Infect Dis 2012; 14:E60-3.
6. Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46:327-60.
7. Johnson LB, Kauffman CA. Voriconazole: a new triazole antifungal agent. Clin Infect Dis 2003; 36:630-7.
8. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347:408-15.
9. Thiel MA, Zinkernagel AS, Burhenne J, Kaufmann C, Haefeli WE. Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis. Antimicrob Agents Chemother 2007; 51:239-44.
10. Sen P, Gopal L, Sen PR. Intravitreal voriconazole for drug-resistant fungal endophthalmitis: case series. Retina 2006; 26:935-9.
11. Jurkunas UV, Langston DP, Colby K. Use of voriconazole in the treatment of fungal keratitis. Int Ophthalmol Clin 2007; 47:47-59.
12. Tortorano AM, Viviani MA, Biraghi E, et al. In vitro testing of fungicidal activity of biocides against Aspergillus fumigatus. J Med Microbiol 2005; 54:955-7.
13. Rahman MR, Johnson GJ, Husain R, Howlader SA, Minassian DC. Randomised trial of 0.2% chlorhexidine gluconate and 2.5% natamycin for fungal keratitis in Bangladesh. Br J Ophthalmol 1998; 82:919-25.
14. Tekce AY, Erbay A, Cabadak H, Yagci S, Karabiber N, Sen S. Pan-resistant Acinetobacter baumannii mediastinitis treated successfully with tigecycline: a case report. Surg Infect 2011; 12:141-3.
15. Lachanas E, Tomos P, Sfyras N, Miyakis S, Kostakis A. Acinetobacter baumannii mediastinitis after cardiopulmonary bypass: case report and literature review. Surg Infect 2008; 9:201-4.
16. George RS, Birks EJ, Haj-Yahia S, et al. Acinetobacter mediastinitis in a heart transplant patient. Ann Thorac Surg 2006; 82:715-6.
17. Jain R MS, Motukupally SR, Jain M. Use of topical colistin in multiple drug-resistant Pseudomonas aeruginosa bacterial keratitis. Cornea. 2014; 33:923-7.